Back
Maze Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
MAZE
Maze Therapeutics, Inc.
Last Price:
$43.66
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAZE is experiencing selling pressure, which indicates risk of future bearish movement.
Maze Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.5 | Sell |
| 20-day SMA: | 42.09 | Buy |
| 50-day SMA: | 40.29 | Buy |
| 200-day SMA: | 23.23 | Buy |
| 8-day EMA: | 17.46 | Buy |
| 20-day EMA: | 8.03 | Buy |
| 50-day EMA: | 3.4 | Buy |
| 200-day EMA: | 0.88 | Buy |
Maze Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.25 | Buy |
| Relative Strength Index (14 RSI): | 54.69 | Buy |
| Chaikin Money Flow: | -405117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.77 - 44.13) | Buy |
| Bollinger Bands (100): | (26.58 - 41.24) | Buy |
Maze Therapeutics, Inc. Technical Analysis
| Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Maze Therapeutics, Inc. Stock
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 43.58 while MAZE 8-day simple moving average is 44.50, which is a Sell signal.
-
The stock price of MAZE is 43.58 while Maze Therapeutics, Inc. 20-day SMA is 42.09, which makes it a Buy.
-
Maze Therapeutics, Inc. 50-day simple moving average is 40.29 while MAZE share price is 43.58, making it a Buy technically.
-
MAZE stock price is 43.58 and Maze Therapeutics, Inc. 200-day simple moving average is 23.23, creating a Buy signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
31
Maze Therapeutics, Inc. (MAZE)
is a Sell
Is Maze Therapeutics, Inc. a Buy or a Sell?
-
Maze Therapeutics, Inc. stock is rated a SellThe current Maze Therapeutics, Inc. [MAZE] share price is $43.58. The Score for MAZE is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics, Inc. Stock Info
Market Cap:
2.1B
Price in USD:
43.58
Share Volume:
486.9K
Maze Therapeutics, Inc. 52-Week Range
52-Week High:
47.36
52-Week Low:
6.71
Sell
31
Maze Therapeutics, Inc. (MAZE)
is a Sell
Maze Therapeutics, Inc. Share Price Forecast
-
What is the Maze Therapeutics, Inc. stock price today?The Maze Therapeutics, Inc. stock price is 43.58 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics, Inc. is overvalued.
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 43.58 while MAZE 8-day exponential moving average is 17.46, which is a Buy signal.
-
The stock price of MAZE is 43.58 while Maze Therapeutics, Inc. 20-day EMA is 8.03, which makes it a Buy.
-
Maze Therapeutics, Inc. 50-day exponential moving average is 3.40 while MAZE share price is 43.58, making it a Buy technically.
-
MAZE stock price is 43.58 and Maze Therapeutics, Inc. 200-day simple moving average is 0.88, creating a Buy signal.
Fundamental Analysis of Maze Therapeutics, Inc.
Is Maze Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.24 per share.
Technical Analysis of Maze Therapeutics, Inc.
Should I short Maze Therapeutics, Inc. stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is 6.25, suggesting Maze Therapeutics, Inc. is a Buy
-
Maze Therapeutics, Inc. Relative Strength Index (RSI) is 54.69, which suggest Maze Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Maze Therapeutics, Inc. is (39.77 - 44.13), which suggest Maze Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Maze Therapeutics, Inc. is (26.58 - 41.24), which suggest Maze Therapeutics, Inc. is a Buy
* Maze Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.